Professor and Chair,Department of Obstetrics, Gynecology and Women's Health, University of Minnesota
Obstetrics & Gynecology
Dr. Linda F. Carson, MD
|
|
Give Review
Dr. Linda F. Carson practices Obstetrics & Gynecology. She attended George Washington University School of Medicine. George Washington University School of Medicine is ranked 67 in research and 0 in primary care medicine She received 4 awards: "CMS Meaningful Use Stage 1 Certification", "Super Doctor", "Fellow (FACOG)" and "Fellow (FACS)". Linda Carson has written publications. She has 101 publications published with PubMed. The lastest paper is: 'The central response to ovarian carcinoma simulates the response to sepsis.'
Publications
- Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian Carcinoma: A pilot study.
- A prospective, randomized trial of integrative medicine for women with ovarian Cancer.
- A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial Cancer.
- Effect of age and comorbidity on the treatment and survival of older patients with vulvar Cancer.
- Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent Carcinoma of the cervix: a phase II trial.
- Learning about ovarian Cancer at the time of diagnosis: video versus usual care.
- A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian Cancer.
- A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian Carcinoma.
- Routine pelvic examination during front-line chemotherapy for ovarian Cancer: should it play a role?
- Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian Cancer.
- Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous Cervical cancer.
- Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
- A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent Cervical cancer.
- Hysteroscopy and cytology in endometrial Cancer.
- A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy.
- A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian Cancer.
- Preoperative detection of peripherally circulating Cancer cells and its prognostic significance in ovarian Cancer.
- Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in Cervical cancer cells.
- Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with Cervical cancer: a gynecologic oncology group study.
- Adenoid cystic Carcinoma of the uterine cervix. Cytologic features.
- Marker rhythmometry with macrophage-colony stimulating factor (M-CSF).
- Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome.
- Are benign cellular changes on a Papanicolaou Smear really benign? A prospective cohort study.
- Multidisciplinary management of urinary pouch complications: a better way.
- Rhabdomyosarcoma with heterologous cartilage of the uterine cervix: a clinicopathologic and immunohistochemical study of an aggressive neoplasm in a young Female.
- Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid Human ovarian tumor cells.
- Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model.
- Uterine malignancy predicted by transvaginal sonography and color flow Doppler ultrasonography.
- Blood flow characteristics of ovarian tumors: implications for ovarian Cancer screening.
- TransVaginal color flow Doppler sonography in the assessment of gestational trophoblastic disease.
- Persistent postmolar gestational trophoblastic disease: use of transVaginal sonography and colour flow Doppler.
- The central response to ovarian Carcinoma simulates the response to sepsis.
- Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian Carcinomas.
- Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian Carcinoma cells isolated from athymic mice.
- TransVaginal ultrasound in gynecologic oncology.
- Human ovarian epithelial Cancer cells cultures in vitro express both interleukin 1 alpha and beta genes.
- Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria Carcinoma.
- Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitot...
- Serum levels of macrophage colony-stimulating factor in patients with ovarian Cancer undergoing second-look laparotomy.
- Expression of cytokine receptors and markers of differentiation in human papillomavirus-infected Cervical tissues.
- Vascular permeability factor gene expression in normal and neoplastic Human ovaries.
- Aminothiadiazole in the treatment of advanced leiomyosarcoma of the Uterine corpus. A Gynecologic Oncology Group study.
- Quality of life assessment in gynaecological Cancer patients.
- Pseudomyxoma peritonei--experience from a tertiary referral centre.
- Phase II trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian Cancer.
- Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal c...
- Symptomatic central venous thrombosis and long-term right atrial catheters.
- Rectus abdominis myocutaneous flap for primary Vaginal reconstruction.
- Secondary cytoreduction--thoughts on the "pro" side.
- A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial Carcinoma: A Gynecologic O...
- Infectious morbidity after radical vulvectomy.
- Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update.
- Gray scale and color flow Doppler characterization of Uterine tumors.
- Activation of c-erbB-2 and prognosis in ovarian Carcinoma. Comparison with histologic type, grade, and stage.
- Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial Cancer cells.
- The integration of whole abdominal radiotherapy and intraperitoneal cisplatin into the primary management of advanced ovarian Carcinoma.
- Sebaceous Carcinoma of the vulva: a case report and review of the literature.
- Association of human immunodeficiency virus-induced immunosuppression with human papillomavirus infection and Cervical intraepithelial neoplasia.
- Transvaginal sonography as an aid in the clinical staging of Carcinoma of the cervix.
- Increased levels of laminin in ascitic fluid of patients with ovarian Cancer.
- Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial Cancer.
- Tolerance and preliminary results of simultaneous therapy with radiation and cisplatin for advanced Cervical cancer.
- Flow characteristics in benign and malignant gynecologic tumors using transVaginal color flow Doppler.
- Invasive vulvar tumors in young women--a disease of the immunosuppressed?
- Chemoprophylaxis with ciprofloxacin in ovarian Cancer patients receiving paclitaxel: a randomized trial.
- A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian Cancer.
- Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?
- Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian Cancer.
- The utility of preoperative screening colonoscopy in gynecologic oncology.
- Erythropoietin increases hemoglobin during radiation therapy for Cervical cancer.
- Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs.
- Clinical features and outcomes of uterine and Ovarian carcinosarcoma.
- A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch).
- Ascites levels of haptoglobin in patients with ovarian Cancer.
- Histogenesis of cervical adenoCarcinoma with reference to human papillomavirus-18 as a carcinogen.
- Human papillomavirus DNA in adenosquamous Carcinoma and squamous cell Carcinoma of the vulva.
- How accurate is the Pelvic examination as compared to transvaginal sonography? A prospective, comparative study.
- Surgical intervention following multimodality therapy for advanced Cervical cancer.
- Multimodality therapy for advanced and recurrent vulvar squamous cell Carcinoma. A pilot project.
- Prognostic significance of the presence of human papillomavirus DNA in patients with invasive Carcinoma of the cervix.
- Concomitant whole-abdominal radiation and intraperitoneal chemotherapy in advanced ovarian Carcinoma. A pilot study.
- Pelvic adhesion formation after Pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model.
- Treatment of advanced epithelial ovarian Carcinoma in pregnancy with cisplatin-based chemotherapy.
- Borderline and invasive epithelial Ovarian tumors in young women.
- Lymph node yield from laparoscopic lymphadenectomy in Cervical cancer: a comparative study.
- The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic Cancer patients.
- Radical vulvectomy with postoperative irradiation for vulvar Cancer: therapeutic implications of a central block.
- Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial Carcinoma.
- Perioperative morbidity and mortality of gynecologic brachytherapy.
- Phase I trial of ifosfamide and 24-h infusional paclitaxel in Pelvic malignancies: a Gynecologic Oncology Group study.
- Cytosolic estrogen and progesterone receptors as prognostic parameters in stage IB cervical Carcinoma.
- Efficacy and tolerability of lower-dose topotecan in recurrent ovarian Cancer: a retrospective case review.
- Vascular endothelial growth factor expression in early stage ovarian Carcinoma.
- Recurrent squamous cell Carcinoma in a rectus abdominis neovagina.
- Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk Cervical cancer: long-term follow-up.
- Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue.
- Management of Pelvic venous stenosis with intravascular stainless steel stents.
- Chemoprophylaxis with oral ciprofloxacin in ovarian Cancer patients receiving taxol.
- Pretreatment surgical staging of patients with cervical Carcinoma: the case for lymph node debulking.
- The implementation of critical pathways in gynecologic oncology in a managed care setting: a cost analysis.
Schools
George Washington University School Of Medicine
Sinai Hospital Of Baltimore
University Of Minnesota
Procedures Preformed
- Colpopexy
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- View All
Conditions Treated
- ASymptomatic Post-Menopausal Status
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACOG)
- Fellow (FACS)
Education
-
Washington University - Barnes-Jewish Hospital -
Sinai Hospital of Baltimore -
George Washington University School of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1760419808 | |
| NPPES Provider LastName | CARSON | |
| NPPES Provider FirstName | LINDA | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 125.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 12.8 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760419808 |
| Last Name Of The Provider | CARSON |
| First Name Of The Provider | LINDA |
| View All |
Similar Doctors
|
|
Dr. Matthew P. Boente, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Argenta, MD
This Doctor is OpenDoctor Recommended.
|